Determining the Impact of Penicillin in Latent RHD: The GOAL Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 807 participants.
Also called NCT03346525
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 807 participants
- Registry
-
NCT03346525
-
- Other papers using this trial's data
- Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Uganda
- Registry status
- Unknown status
Technical summary
Registry record NCT03346525. Randomized; single masking; primary purpose treatment. Start 2018-06-26 (actual); primary completion 2020-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Determining the Impact of Penicillin in Latent RHD: The GOAL Trial
- Acronym
- GOAL
- Condition
- Rheumatic Heart Disease in Children
- Condition
- Latent Rheumatic Heart Disease
- Condition
- Rheumatic Heart Disease
- Condition
- Heart Diseases
- Intervention (Drug)
- intramuscular benzathine penicillin G (BPG) prophylaxis
- Lead sponsor
- Children's National Research Institute
- Collaborator
- Thrasher Research Fund
- Collaborator
- University of Cape Town
- Collaborator
- Uganda Heart Institute
- Collaborator
- Karp Family Foundation
- Collaborator
- Gift of Life International
- Collaborator
- Murdoch Childrens Research Institute
Record details
- Record id
cardio:ct-nct03346525- Content hash
313de4bd0d160cba2c4fbab872c99060356d68ed4f34abd4c8bd4a8b24642eee